410 related articles for article (PubMed ID: 18079493)
1. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.
Sethi S; Wrona C; Eschberger K; Lobbins P; Cai X; Murphy TF
Am J Respir Crit Care Med; 2008 Mar; 177(5):491-7. PubMed ID: 18079493
[TBL] [Abstract][Full Text] [Related]
2. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.
Hurst JR; Perera WR; Wilkinson TM; Donaldson GC; Wedzicha JA
Am J Respir Crit Care Med; 2006 Jan; 173(1):71-8. PubMed ID: 16179639
[TBL] [Abstract][Full Text] [Related]
3. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
4. Relationship between airway colonization, inflammation and exacerbation frequency in COPD.
Tumkaya M; Atis S; Ozge C; Delialioglu N; Polat G; Kanik A
Respir Med; 2007 Apr; 101(4):729-37. PubMed ID: 17002892
[TBL] [Abstract][Full Text] [Related]
5. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease.
Sethi S; Sethi R; Eschberger K; Lobbins P; Cai X; Grant BJ; Murphy TF
Am J Respir Crit Care Med; 2007 Aug; 176(4):356-61. PubMed ID: 17478618
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
8. Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.
Parameswaran GI; Wrona CT; Murphy TF; Sethi S
BMC Infect Dis; 2009 Nov; 9():178. PubMed ID: 19912665
[TBL] [Abstract][Full Text] [Related]
9. Airway inflammation and etiology of acute exacerbations of chronic bronchitis.
Sethi S; Muscarella K; Evans N; Klingman KL; Grant BJ; Murphy TF
Chest; 2000 Dec; 118(6):1557-65. PubMed ID: 11115440
[TBL] [Abstract][Full Text] [Related]
10. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
Sethi S; Evans N; Grant BJ; Murphy TF
N Engl J Med; 2002 Aug; 347(7):465-71. PubMed ID: 12181400
[TBL] [Abstract][Full Text] [Related]
11. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
[TBL] [Abstract][Full Text] [Related]
12. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
13. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
14. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease.
Murphy TF
Curr Opin Infect Dis; 2006 Jun; 19(3):225-30. PubMed ID: 16645482
[TBL] [Abstract][Full Text] [Related]
15. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.
Basyigit I; Yildiz F; Ozkara SK; Yildirim E; Boyaci H; Ilgazli A
Ann Pharmacother; 2004 Sep; 38(9):1400-5. PubMed ID: 15252191
[TBL] [Abstract][Full Text] [Related]
16. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.
Seemungal TA; Wilkinson TM; Hurst JR; Perera WR; Sapsford RJ; Wedzicha JA
Am J Respir Crit Care Med; 2008 Dec; 178(11):1139-47. PubMed ID: 18723437
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-{alpha} rs361525 polymorphism is associated with increased local production and downstream inflammation in chronic obstructive pulmonary disease.
Sapey E; Wood AM; Ahmad A; Stockley RA
Am J Respir Crit Care Med; 2010 Jul; 182(2):192-9. PubMed ID: 20299531
[TBL] [Abstract][Full Text] [Related]
18. Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers.
Chin CL; Manzel LJ; Lehman EE; Humlicek AL; Shi L; Starner TD; Denning GM; Murphy TF; Sethi S; Look DC
Am J Respir Crit Care Med; 2005 Jul; 172(1):85-91. PubMed ID: 15805181
[TBL] [Abstract][Full Text] [Related]
19. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
[TBL] [Abstract][Full Text] [Related]
20. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
